Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Changsha Dadi Medicine Research Institute is a Chinese research and development organization specializing in Traditional Chinese Medicine (TCM) and dermatological therapeutics. Based in Changsha, Hunan province, the institute was established to bridge the gap between ancient herbal wisdom and modern clinical requirements. It is primarily recognized for its proprietary formulations targeting chronic skin conditions such as psoriasis, eczema, and severe burns. The institute conducts independent R&D and collaborates with domestic pharmaceutical manufacturers to bring TCM-based treatments to the commercial market. Its portfolio includes a range of topical and oral medicinal products that have gained significant usage within the Chinese healthcare system.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Changsha Dadi Medicine Research Institute.